Aytu BioPharma (AYTU)
(Delayed Data from NSDQ)
$2.85 USD
+0.03 (1.06%)
Updated Jul 18, 2024 03:59 PM ET
After-Market: $2.85 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AYTU 2.85 +0.03(1.06%)
Will AYTU be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AYTU based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AYTU
ANI Pharmaceuticals (ANIP) Beats Q1 Earnings and Revenue Estimates
Aytu BioPharma Inc. (AYTU) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
AYTU: What are Zacks experts saying now?
Zacks Private Portfolio Services
Bears are Losing Control Over Aytu BioPharma Inc. (AYTU), Here's Why It's a 'Buy' Now
Other News for AYTU
Aytu BioScience’s Strategic Debt Moves Prompt Buy Rating
Aytu Biopharma announces paydown and refinancing of term loan
Aytu BioScience Bolsters Growth with Strategic Financial Moves
Aytu BioPharma announces paydown, refinancing of term loan
Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms